Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-31 @ 11:03 AM
Study NCT ID:
NCT07310069
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-12-30
First Post:
2025-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer
Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
XHEC-C-2025-111-4
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None